| Clayton Edward Strong, MD | |
|
2200 Forest Ridge Pkwy, Suite 240, New Castle, IN 47362-2943 | |
| (765) 521-7385 | |
| (765) 521-7394 |
| Full Name | Clayton Edward Strong |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 13 Years |
| Location | 2200 Forest Ridge Pkwy, New Castle, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013203843 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 01077136A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Suburban Home Health Llc | Noblesville, IN | Home health agency |
| Hancock Regional Hospital | Greenfield, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hancock Physician Network, Llc | 8325952633 | 107 |
| Hancock Regional Hospital | 1850205162 | 45 |
News Archive
"As representatives of the World Health Organization Member States arrive in Geneva this week for the 65th World Health Assembly, I feel a cautious optimism about the future, and the future health of Africa," Joy Phumaphi, co-chair of the Aspen Global Leaders Council for Reproductive Health, writes in this post in the Huffington Post Blog.
Featured in the October edition of the Journal of Thoracic Oncology (JTO), data from The Tarceva Lung Cancer Survival Treatment (TRUST) confirms the safety and efficacy profile of erlotinib, a highly potent oral active, reversible inhibitor of epidermal growth factor receptor (EGFR) tyrosine-kinase (TK) activity in a large heterogeneous non-small cell lung cancer (NSCLC) population.
Cepheid today announced that its Xpert® MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance." The complete study is now available online (http://www.nejm.org) and will appear in the September 9 print edition.
In a study to be presented on February 14 between 1:15 p.m., and 3:30 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, California, researchers will present findings showing perinatal outcomes of frozen/thawed embryo replacement (FER) have better outcomes compared to fresh in vitro fertilization (IVF), but worse outcomes compared to the non-IVF general population.
› Verified 6 days ago
| Entity Name | Henry County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891570537 PECOS PAC ID: 6002724085 Enrollment ID: O20031121000221 |
News Archive
"As representatives of the World Health Organization Member States arrive in Geneva this week for the 65th World Health Assembly, I feel a cautious optimism about the future, and the future health of Africa," Joy Phumaphi, co-chair of the Aspen Global Leaders Council for Reproductive Health, writes in this post in the Huffington Post Blog.
Featured in the October edition of the Journal of Thoracic Oncology (JTO), data from The Tarceva Lung Cancer Survival Treatment (TRUST) confirms the safety and efficacy profile of erlotinib, a highly potent oral active, reversible inhibitor of epidermal growth factor receptor (EGFR) tyrosine-kinase (TK) activity in a large heterogeneous non-small cell lung cancer (NSCLC) population.
Cepheid today announced that its Xpert® MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance." The complete study is now available online (http://www.nejm.org) and will appear in the September 9 print edition.
In a study to be presented on February 14 between 1:15 p.m., and 3:30 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, California, researchers will present findings showing perinatal outcomes of frozen/thawed embryo replacement (FER) have better outcomes compared to fresh in vitro fertilization (IVF), but worse outcomes compared to the non-IVF general population.
› Verified 6 days ago
| Entity Name | Hancock Physician Network, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609806470 PECOS PAC ID: 8325952633 Enrollment ID: O20040130000777 |
News Archive
"As representatives of the World Health Organization Member States arrive in Geneva this week for the 65th World Health Assembly, I feel a cautious optimism about the future, and the future health of Africa," Joy Phumaphi, co-chair of the Aspen Global Leaders Council for Reproductive Health, writes in this post in the Huffington Post Blog.
Featured in the October edition of the Journal of Thoracic Oncology (JTO), data from The Tarceva Lung Cancer Survival Treatment (TRUST) confirms the safety and efficacy profile of erlotinib, a highly potent oral active, reversible inhibitor of epidermal growth factor receptor (EGFR) tyrosine-kinase (TK) activity in a large heterogeneous non-small cell lung cancer (NSCLC) population.
Cepheid today announced that its Xpert® MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance." The complete study is now available online (http://www.nejm.org) and will appear in the September 9 print edition.
In a study to be presented on February 14 between 1:15 p.m., and 3:30 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, California, researchers will present findings showing perinatal outcomes of frozen/thawed embryo replacement (FER) have better outcomes compared to fresh in vitro fertilization (IVF), but worse outcomes compared to the non-IVF general population.
› Verified 6 days ago
| Entity Name | Hancock Regional Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255418356 PECOS PAC ID: 1850205162 Enrollment ID: O20040401000258 |
News Archive
"As representatives of the World Health Organization Member States arrive in Geneva this week for the 65th World Health Assembly, I feel a cautious optimism about the future, and the future health of Africa," Joy Phumaphi, co-chair of the Aspen Global Leaders Council for Reproductive Health, writes in this post in the Huffington Post Blog.
Featured in the October edition of the Journal of Thoracic Oncology (JTO), data from The Tarceva Lung Cancer Survival Treatment (TRUST) confirms the safety and efficacy profile of erlotinib, a highly potent oral active, reversible inhibitor of epidermal growth factor receptor (EGFR) tyrosine-kinase (TK) activity in a large heterogeneous non-small cell lung cancer (NSCLC) population.
Cepheid today announced that its Xpert® MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance." The complete study is now available online (http://www.nejm.org) and will appear in the September 9 print edition.
In a study to be presented on February 14 between 1:15 p.m., and 3:30 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, California, researchers will present findings showing perinatal outcomes of frozen/thawed embryo replacement (FER) have better outcomes compared to fresh in vitro fertilization (IVF), but worse outcomes compared to the non-IVF general population.
› Verified 6 days ago
| Entity Name | New Castle Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801964960 PECOS PAC ID: 3274528757 Enrollment ID: O20041111000692 |
News Archive
"As representatives of the World Health Organization Member States arrive in Geneva this week for the 65th World Health Assembly, I feel a cautious optimism about the future, and the future health of Africa," Joy Phumaphi, co-chair of the Aspen Global Leaders Council for Reproductive Health, writes in this post in the Huffington Post Blog.
Featured in the October edition of the Journal of Thoracic Oncology (JTO), data from The Tarceva Lung Cancer Survival Treatment (TRUST) confirms the safety and efficacy profile of erlotinib, a highly potent oral active, reversible inhibitor of epidermal growth factor receptor (EGFR) tyrosine-kinase (TK) activity in a large heterogeneous non-small cell lung cancer (NSCLC) population.
Cepheid today announced that its Xpert® MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance." The complete study is now available online (http://www.nejm.org) and will appear in the September 9 print edition.
In a study to be presented on February 14 between 1:15 p.m., and 3:30 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, California, researchers will present findings showing perinatal outcomes of frozen/thawed embryo replacement (FER) have better outcomes compared to fresh in vitro fertilization (IVF), but worse outcomes compared to the non-IVF general population.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Clayton Edward Strong, MD Po Box 530, New Castle, IN 47362-0530 Ph: (765) 521-7385 | Clayton Edward Strong, MD 2200 Forest Ridge Pkwy, Suite 240, New Castle, IN 47362-2943 Ph: (765) 521-7385 |
News Archive
"As representatives of the World Health Organization Member States arrive in Geneva this week for the 65th World Health Assembly, I feel a cautious optimism about the future, and the future health of Africa," Joy Phumaphi, co-chair of the Aspen Global Leaders Council for Reproductive Health, writes in this post in the Huffington Post Blog.
Featured in the October edition of the Journal of Thoracic Oncology (JTO), data from The Tarceva Lung Cancer Survival Treatment (TRUST) confirms the safety and efficacy profile of erlotinib, a highly potent oral active, reversible inhibitor of epidermal growth factor receptor (EGFR) tyrosine-kinase (TK) activity in a large heterogeneous non-small cell lung cancer (NSCLC) population.
Cepheid today announced that its Xpert® MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance." The complete study is now available online (http://www.nejm.org) and will appear in the September 9 print edition.
In a study to be presented on February 14 between 1:15 p.m., and 3:30 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, California, researchers will present findings showing perinatal outcomes of frozen/thawed embryo replacement (FER) have better outcomes compared to fresh in vitro fertilization (IVF), but worse outcomes compared to the non-IVF general population.
› Verified 6 days ago
Anjan P Kaushik, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2200 Forest Ridge Pkwy, New Castle, IN 47362 Phone: 765-521-7385 | |
Dr. Kyle William Siewert, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2200 Forest Ridge Pkwy, Suite 240, New Castle, IN 47362 Phone: 765-521-7385 Fax: 765-521-7394 | |
Dr. Lindsey R Rolston, M.D Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2200 Forest Ridge Pkwy, Suite #240, New Castle, IN 47362 Phone: 765-521-7385 Fax: 765-521-7394 | |
Dr. Thomas J. Mathews, M.D Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2200 Forest Ridge Pkwy, Suite #240, New Castle, IN 47362 Phone: 765-521-7385 Fax: 765-521-7394 | |
Dr. Damion M. Harris, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2200 Forest Ridge Pkwy, Suite #240, New Castle, IN 47362 Phone: 765-521-7385 Fax: 765-521-7394 |